Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 21,120 shares at $55.10 ($1.1M) on 2026-04-28, disclosed to the SEC on 2026-04-30.
Scheduled sale ($1.1M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.10 | 1,652 | $91K | 8.0% |
| 2 | $56.06 | 4,591 | $257K | 22.6% |
| 3 | $56.69 | 797 | $45K | 4.0% |
| 4 | $52.70 | 4,002 | $211K | 18.5% |
| 5 | $53.21 | 3,038 | $162K | 14.2% |
| 6 | $52.65 | 5,805 |
| $306K |
| 26.9% |
| 7 | $53.32 | 1,235 | $66K | 5.8% |
| Total | $53.86 avg | 21,120 | $1.1M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |
| PAHC | SELL | 2026-03-26 | $2.3M | — | Filing → |